T-cell immunodeficiency with thymic aplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:83471OMIM:242700D81.4
Who is this for?
Show terms as
1FDA treatments2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

Aplasia of the thymusHP:0005359Severe T-cell immunodeficiencyHP:0005352Cellular immunodeficiencyHP:0005374Decreased total T cell countHP:0005403Decreased mitogen-induced T-cell proliferationHP:0031381Decreased naive T cell proportionHP:0031397Recurrent infection of the gastrointestinal tractHP:0004798Opportunistic infectionHP:0031690Severe viral infectionHP:0031691
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Oct 2021

Rethymic: FDA approved

immune reconstitution in pediatric patients with congenital athymia

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Rethymic

allogeneic processed thymus tissue-agdc· Enzyvant Therapeutics GmbHOrphan Drug

immune reconstitution in pediatric patients with congenital athymia

No actively recruiting trials found for T-cell immunodeficiency with thymic aplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the T-cell immunodeficiency with thymic aplasia community →

Specialists

2 foundView all specialists →
JM
John W. Sleasman, M.D.
DURHAM, NC
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to T-cell immunodeficiency with thymic aplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open T-cell immunodeficiency with thymic aplasiaForum →

No community posts yet. Be the first to share your experience with T-cell immunodeficiency with thymic aplasia.

Start the conversation →

Latest news about T-cell immunodeficiency with thymic aplasia

No recent news articles for T-cell immunodeficiency with thymic aplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about T-cell immunodeficiency with thymic aplasia

Which specialists treat T-cell immunodeficiency with thymic aplasia?

2 specialists and care centers treating T-cell immunodeficiency with thymic aplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for T-cell immunodeficiency with thymic aplasia?

1 patient support program are currently tracked on UniteRare for T-cell immunodeficiency with thymic aplasia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.